North China Pharmaceutical released the third quarter report for 2024, achieving revenue of 7.56 billion yuan in the first three quarters, a decrease of 5.20% year-on-year; with a net income of 0.102 billion yuan, an increase of 266.29% year-on-year. In the third quarter alone, revenue reached 2.329 billion yuan, a decrease of 15.04% year-on-year; net income was 30.4792 million yuan, an increase of 2035.13% year-on-year.